Public COA audit

Triple Agonist

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
93%
Panels
3/7
Purity (printed)
99.8%

Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (3/7), and 1 soft concern. To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-3XAG10-2603-1
Identity method
FTIR (USP <197A>)
Sample date
2026-04-02
Issue date
2026-04-05

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    FTIR sample spectrum confirms the presence of Triple Agonist with addition of excipient(s)/fillers

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.8%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    18.0 EU/vial (limit: 40 EU/vial)

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High HPLC purity achieved

    99.8% purity by HPLC (USP <621>) exceeds specification of ≥98%. This is normal for research-grade peptides and not a red flag.

  • Identity confirmed by FTIR

    FTIR spectrum confirms presence of Triple Agonist with excipients/fillers, consistent with formulated peptide product.

  • Endotoxin testing performed separately

    Endotoxin testing documented on separate report (IF-824-QSA-TR006-BTL26130-21) dated 4/10/2026, showing PASS at 18.0 EU/vial (limit 40 EU/vial) via gel clot LAL method.

  • Batch/lot number clearly stated

    Lot CR-3XAG10-2603-1 consistently referenced across both purity and endotoxin reports.

  • Dates are consistent and valid

    Sample tested 4/2/2026, report issued 4/5/2026; endotoxin tested 4/8/2026, issued 4/10/2026. All dates are on or before 2026-09-05 and logically sequenced.

  • Lab information provided

    BTLabs, West Palm Beach FL, with contact info and website. QR code present for verification.

  • Heavy metals, microbial, sterility, and residual solvent testing not included

    Document explicitly states testing does not cover particulate matter, microbial contamination beyond endotoxins. This is common for basic peptide COAs but limits comprehensive safety assessment.

  • Professional formatting with supporting data

    Includes FTIR spectrum, HPLC chromatogram, triplicate measurements for mass/potency, peptide-to-excipient ratios, and dual scientist signatures.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.